HIV (Transmission Risk): Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{| style="width: 500px" border="1" cellpadding="1" cellspacing="1" | {| style="width: 500px" border="1" cellpadding="1" cellspacing="1" | ||
|- | |- | ||
| '''Exposure<br/>''' | | '''Exposure^'''<br/> | ||
| '''Risk'''<br/> | |||
|- | |- | ||
| Percutaneous | | Percutaneous | ||
| Line 18: | Line 18: | ||
| 0.5% | | 0.5% | ||
|- | |- | ||
| Receptive penile-vaginal intercourse | | Receptive penile-vaginal intercourse | ||
| 0.1% | | 0.1% | ||
|- | |- | ||
| Line 34: | Line 34: | ||
|} | |} | ||
^assumes no condom use | |||
== Source == | == Source == | ||
8/07 DONALDSON | 8/07 DONALDSON | ||
[[Category:ID]] | |||
Revision as of 04:32, 28 March 2011
Exposure Estimated Risk
| Exposure^ |
Risk |
| Percutaneous | 0.3% |
| Mucocutaneous | 0.09% |
| Needle-sharing injection drug | 0.7% |
| Receptive anal intercourse | 0.5% |
| Receptive penile-vaginal intercourse | 0.1% |
| Insertive anal intercourse | 0.07% |
| Insertive penile-vaginal intercourse | 0.05% |
| Receptive oral (male) intercourse | 0.01% |
| Insertive oral (male) intercourse | 0.005% |
^assumes no condom use
Source
8/07 DONALDSON